Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615000625572Phase 4Completed
Phase 4, randomised, double-blind trial comparing Midazolam + propofol with Saline placebo + propofol (2 arms). Primary endpoint: Incidence of cognitive recovery at day 3. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615000625572.